Circulating Tumor Cell: Clinical Trials

1 trial for Circulating Tumor Cell, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 not yet recruiting. 1 Early Phase 1.

By phase and status

PhaseTrialsStatus
Early Phase 11Not yet recruiting 1

Follow Circulating Tumor Cell: new trials by email Literature Review of Circulating Tumor Cell trials Research Report on Circulating Tumor Cell

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
CSF CTC-Capture-Guided EGFR-TKI and Bevacizumab Combination Therapy in EGFR-Mutant Advanced NSCLC
Osimertinib 80 MG, Bevacizumab - Non Small Cell Lung Cancer, Circulating Tumor Cell
Early Phase 1Not yet recruitingSecond Affiliated Hospital of Nanchang University1002024-08-202024-08-16

Narrower conditions

Carcinoma, Non-Small-Cell Lung (1)  ·  Neoplastic Cells, Circulating (1)

Broader conditions

Bronchial Neoplasms (1)  ·  Carcinoma, Bronchogenic (1)  ·  Lung Diseases (1)  ·  Lung Neoplasms (1)  ·  Neoplasm Metastasis (1)  ·  Neoplasms (1)  ·  Neoplasms by Site (1)  ·  Neoplastic Processes (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Respiratory Tract Diseases (1)  ·  Respiratory Tract Neoplasms (1)  ·  Thoracic Neoplasms (1)

Interventions

Bevacizumab (1)  ·  osimertinib (1)

Sponsors

Second Affiliated Hospital of Nanchang University (1)

Top investigators

Lin Chuyang, Director (1)